High Quality Cas 183552-38-7 - Telipressin acetate for injection – JYMed

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We consistently carry out our spirit of ''Innovation bringing development, Highly-quality ensuring subsistence, Management promoting benefit, Credit attracting customers for C76h104n18o19s2, Cas 183552-38-7, Pramlintide Acetate Gmp Supplier, Besides, our enterprise sticks to high-quality and fair value, and we also offer you fantastic OEM solutions to several famous brands.
High Quality Cas 183552-38-7 - Telipressin acetate for injection – JYMed Detail:

Terlipressin Acetate for injection

1mg/vial   Strength

Indication: For the treatment of esophageal variceal bleeding.

Clinical application: intravenous injection.

Terlipress in acetate EVER Pharma 0.2 mg/ml solution for injection contains the active ingredient terlipress in, which is a synthetic pituitary hormone (this hormone is usually produced by the pituitary gland found in the brain).

It will be given to you by injection into a vein.

Terlipress in acetate EVER Pharma 0.2 mg/ml solution for injection is used for the treatment of:

• bleeding from dilated (widening) veins in the food pipe leading to your stomach (called bleeding oesophageal varices).

• emergency treatment of type 1 hepatorenal syndrome (rapidly progressive renal failure) in patients with liver cirrhosis (scarring of the liver) and ascites (abdominal dropsy).

This medicine will always be given to you by a doctor into your vein. The doctor will decide the most appropriate dose for you and your heart and blood circulation will be continuously monitored during the injection. Please ask your doctor for further information regarding its use.

Use in adults

1. Short term management of bleeding oesophageal varices

Initially 1-2 mg terlipress in acetate (5-10 ml of Terlipress in acetate EVER Pharma 0.2 mg/ml solution for injection) is given by injection into your vein. Your dose will depend on your body weight.

After the initial injection, your dose may be reduced to 1 mg terlipress in acetate (5 ml) every 4 to 6 hours.

2. Type 1 hepatorenal syndrome

The usual dose is 1 mg terlipress in acetate every 6 hours for at least 3 days. If the reduction of serum creatinine is less than 30 % after 3 days of treatment your doctor should consider doubling the dose to 2 mg every 6 hours.

If there is no response to Terlipress in acetate EVER Pharma 0.2 mg/ml solution for injection or in patients with complete response, treatment with Terlipress in acetate EVER Pharma 0.2 mg/ml solution for injection should be interrupted.

When a reduction in serum creatinine is seen, treatment with Terlipress in acetate EVER Pharma 0.2 mg/ml solution for injection should be maintained to a maximum of 14 days.

Use in the elderly

If you are over 70 years of age speak with your doctor before you receive Terlipress in acetate EVER Pharma 0.2 mg/ml solution for injection.

Use in patients with kidney problems

Terlipress in acetate EVER Pharma 0.2 mg/ml solution for injection should be used with caution in patients with long standing kidney failure.

Use in patients with liver problems

No dose adjustment is required in patients with liver failure.

Use in children and adolescents

Terlipress in acetate EVER Pharma 0.2 mg/ml solution for injection is not recommended for use in children and adolescents due to insufficient experience.

Duration of treatment

The use of this medicine is limited to 2 – 3 days for short term management of bleeding oesophageal varices and to a maximum of 14 days for treatment of type 1 hepatorenal syndrome, depending on the course of your condition.


Product detail pictures:

High Quality Cas 183552-38-7 - Telipressin acetate for injection – JYMed detail pictures


Related Product Guide:
Steps Closer to the Adoption of Continuous Processing | Lanreotide
Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells | Trelstar(Triptorelin Pamoate)

Our primary goal is to offer our clients a serious and responsible business relationship, providing personalized attention to all of them for High Quality Cas 183552-38-7 - Telipressin acetate for injection – JYMed , The product will supply to all over the world, such as: Hungary, Jeddah, Bulgaria, We hope to have long-term cooperation relationships with our clients. If you are interested in any of our products, make sure you do not hesitate to send enquiry to us/company name. We ensure that you can be totally satisfied with our best solutions!
  • This manufacturer can keep improving and perfecting products and service, it is in line with the rules of market competition, a competitive company.
    5 Stars By Lena from Iceland - 2015.06.26 19:27
    The customer service staff's attitude is very sincere and the reply is timely and very detailed, this is very helpful for our deal,thank you.
    5 Stars By Andy from Rwanda - 2016.04.28 15:45
    Write your message here and send it to us